| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |